← SynDRA
2-Cyano-3-(1-phenylindol-3-yl)acrylate
SynDRA canonical compound SYN1947489 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | SLC16A1 |
|---|
| Mechanism of action | monocarboxylate transporter inhibitor |
|---|
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Cross-references
Synonyms
- 2-Cpiya
- alpha-Cyano-beta-(1-phenylindol-3-yl)acrylate
- RefChem:86556
- UK 5099
- (E)-2-cyano-3-(1-phenylindol-3-yl)prop-2-enoic acid
- MFCD19443867
- UK5099
- (E)-2-cyano-3-(1-phenyl-1H-indol-3-yl)acrylic acid
- JXL001
- 2-Cyano-3-(1-phenyl-1H-indol-3-yl)-acrylic acid
- 2-Cyano-3-(1-phenyl-3-indolyl)acrylic Acid
- 2-Cyano-3-(1-phenyl-1H-indol-3-yl)acrylic acid
- PF-1005023
- I2R
- PF-06340678
- SCHEMBL16620642
- SCHEMBL29390068
- GTPL11302
- CHEBI:232354
- GLXC-05831
- HMS6018H15
- EX-A1928
- BDBM50608638
- NSC784390
- s5317
- AKOS024458020
- CCG-267359
- EBC-498105
- FU65200
- NSC-784390
- NCGC00387143-06
- AC-36255
- AS-63568
- HY-15475
- SY389339
- UK-5099?
- T4441
- UK-5099, >=98% (HPLC)
- UK5099; PF-1005023
Look up 2-Cyano-3-(1-phenylindol-3-yl)acrylate in the interactive SynDRA portal →